Posts

Educational News Highlights in India: 16th to 23rd September 2024

### Educational News Highlights in India: 16th to 23rd September 2024 This detailed report covers the major educational news in India between 16th September 2024 and 23rd September 2024. From global appeals addressing the education crisis to innovative initiatives introduced by premier Indian institutes, this week witnessed significant updates affecting children, schools, and educational policies across the country. --- ### 1. [UNICEF Appeals for $58.8 Million to Address Education Crisis (16th September 2024)](https://www.unicef.org/media/press-releases) On 16th September 2024, UNICEF launched a global appeal for US$58.8 million to address the growing education crisis affecting school-age children, particularly those aged 5 to 19. The appeal is focused on providing support for children in conflict-ridden and disaster-affected areas, where educational disruptions have been severe. Millions of children across the world have been displaced from schools due to natural disasters, armed conf

Health News Highlights: 16th to 23rd September 2024

### Health News Highlights: 16th to 23rd September 2024 In this week's health news roundup, we cover significant developments that occurred between 16th September (Monday) and 23rd September 2024 (Monday). The focus spans from groundbreaking treatments for migraines to generative AI's impact on primary healthcare, antibiotic resistance efforts, global health emergency updates, and Supreme Court rulings affecting healthcare in the U.S. Dive into the comprehensive analysis of these stories, which highlight the progress and challenges in global health systems. --- ### 1. Triptans Found to Relieve Migraine Pain Better Than Recent Drugs (23rd September 2024) In a study published on 23rd September 2024, Triptans—a long-established class of drugs for treating migraines—were shown to outperform newer medications. Research highlighted that Triptans, which reduce blood vessel swelling in the brain, offer faster and more consistent relief than recently introduced drugs like CGRP inhibitor